British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

Christopher A Lamb(Newcastle upon Tyne Hospitals NHS Foundation Trust), Nicholas A. Kennedy(University of Exeter), Tim Raine(Cambridge University Hospitals NHS Foundation Trust), Philip Hendy(Chelsea and Westminster Hospital NHS Foundation Trust), Philip J Smith(Royal Liverpool and Broadgreen University Hospital NHS Trust), Jimmy K. Limdi(Pennine Acute Hospitals NHS Trust), Bu Hayee(King's College London), Miranda Lomer(King's College London), Gareth Parkes(Queen Mary University of London), Christian P. Selinger(University of Leeds), Kevin Barrett, Justin Davies(University of Cambridge), Cathy Bennett(Royal College of Surgeons in Ireland), Stuart Gittens, Malcolm G. Dunlop(Western General Hospital), Omar Faiz(St Mark's Hospital), Aileen Fraser(University Hospitals Bristol NHS Foundation Trust), Vikki Garrick(Royal Hospital for Children), Paul D Johnston(Crohn's and Colitis UK), Miles Parkes(Cambridge University Hospitals NHS Foundation Trust), Jeremy Sanderson(King's College London), Helen Terry(Crohn's and Colitis UK), IBD guidelines eDelphi consensus group(Glasgow Royal Infirmary), Daniel R. Gaya(Queen Elizabeth Hospital Birmingham), Tariq Iqbal(University College London Hospitals NHS Foundation Trust), Stuart A. Taylor(Brighton and Sussex Medical School), Melissa Smith(Brighton and Sussex Medical School), Matthew Brookes(University of Wolverhampton), Richard Hansen(Royal Hospital for Children), A. B. Hawthorne(University Hospital of Wales)
Gut
September 27, 2019
Cited by 2,305Open Access
Full Text

Abstract

Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease. Both represent chronic inflammation of the gastrointestinal tract, which displays heterogeneity in inflammatory and symptomatic burden between patients and within individuals over time. Optimal management relies on understanding and tailoring evidence-based interventions by clinicians in partnership with patients. This guideline for management of inflammatory bowel disease in adults over 16 years of age was developed by Stakeholders representing UK physicians (British Society of Gastroenterology), surgeons (Association of Coloproctology of Great Britain and Ireland), specialist nurses (Royal College of Nursing), paediatricians (British Society of Paediatric Gastroenterology, Hepatology and Nutrition), dietitians (British Dietetic Association), radiologists (British Society of Gastrointestinal and Abdominal Radiology), general practitioners (Primary Care Society for Gastroenterology) and patients (Crohn's and Colitis UK). A systematic review of 88 247 publications and a Delphi consensus process involving 81 multidisciplinary clinicians and patients was undertaken to develop 168 evidence- and expert opinion-based recommendations for pharmacological, non-pharmacological and surgical interventions, as well as optimal service delivery in the management of both ulcerative colitis and Crohn's disease. Comprehensive up-to-date guidance is provided regarding indications for, initiation and monitoring of immunosuppressive therapies, nutrition interventions, pre-, peri- and postoperative management, as well as structure and function of the multidisciplinary team and integration between primary and secondary care. Twenty research priorities to inform future clinical management are presented, alongside objective measurement of priority importance, determined by 2379 electronic survey responses from individuals living with ulcerative colitis and Crohn's disease, including patients, their families and friends.


Related Papers

No related papers found

Powered by citation graph analysis